Related Experiment Video
Updated: Aug 8, 2026
08:54
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Multistage carcinogenesis in Barrett's esophagus
1The Wistar Institute, Cellular and Molecular Oncogenesis, 3601 Spruce Street, Philadelphia, PA 19104, USA. cmaley@alum.mit.edu
Cancer Letters
|May 23, 2006
Summary
Esophageal adenocarcinoma develops through clonal evolution in Barrett's esophagus. Early CDKN2A inactivation and later TP53 inactivation drive cancer progression, with genetic instability preceding invasion.
Area of Science:
- Oncology
- Evolutionary Biology
- Gastroenterology
Background:
- Esophageal adenocarcinoma (EAC) multistage carcinogenesis involves clonal evolution within Barrett's esophagus (BE) neoplasms.
- Chronic gastric reflux is associated with BE initiation and progression, though the precise initiating event remains unknown.
- Understanding the genetic events driving EAC progression is crucial for developing effective prevention strategies.
Purpose of the Study:
- To elucidate the multistage process of esophageal adenocarcinoma carcinogenesis.
- To identify key genetic events and clonal evolution patterns in Barrett's esophagus.
- To explore the application of evolutionary biology principles in cancer prevention.
Main Methods:
- Analysis of clonal evolution in Barrett's esophagus neoplasms.
- Examination of genetic alterations, including CDKN2A and TP53 inactivation.
- Application of evolutionary biology frameworks to cancer progression.
Main Results:
- Inactivation of both CDKN2A alleles appears to be an early event promoting clonal expansion.
- Clonal expansion with TP53 inactivation occurs subsequent to CDKN2A inactivation.
- Development of tetraploid and aneuploid clones is observed after TP53 inactivation, preceding invasion.
Conclusions:
- The multistage carcinogenesis of EAC is characterized by distinct phases of clonal evolution.
- CDKN2A and TP53 inactivation are critical early and intermediate events in EAC development.
- Evolutionary biology offers valuable insights into EAC progression and potential prevention targets.
Related Concept Videos
01:21Barrett Esophagus-I: Introduction
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
01:21Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
01:24Cellular Adaptation IV: Dysplasia and Metaplasia
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
01:30Esophageal Strictures-I: Introduction
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...